Generics & Biosimilars | Association for Accessible Medicines
New Blog - Jonathan Kimball gives more detail re: AAM's blueprint & proposed policy framework
  • Over business lady's shoulder who looks at computer screen where collage of many diverse women involved at a video conference
    WiHP + LinkedIn Rock Your Profile
    WiHP members (powered by AAM) can learn first hand how to grow their health policy network and learn best practices to build a personal brand that is set up for success. July 15 at 11AM ET. Limited to first 100 registrations.
  • GRx+Biosims 2020: Generics + Biosimilars Virtual Conference
    We Are Going Virtual!
    CONNECT + SHARE at the GRx+Biosims 2020 virtual conference. This year—wherever you are located—you can be part of the only online experience for generics and biosimilars professionals. Join us on November 9-11.
  • AAM Blueprint U.S. Supply Chain
    Securing the U.S. Rx Supply Chain
    The generic drug industry in the U.S. can expand domestically to increase national security, lessen dependence on any single country and create more jobs. Learn about our plan.
  • ""
    Industry Response to COVID-19
    The coronavirus (COVID-19) pandemic is disrupting everyday life around the world and imposing unprecedented stress on our health care system. Here are some responses and resources from the U.S. generics and biosimilars industry.

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.